Tübingen

At DZIF's Tübingen partner site, the University and University Hospital of Tübingen and the Max-Planck Institute for Developmental Biology have combined their strengths to tackle several grand challenges. Within DZIF, they are coordinating and strategically aligning translational infection research with the aim of developing new diagnostic, preventative and therapeutic methods for treating infectious diseases.

The Tübingen researchers have dedicated themselves above all to projects on malaria, infections of the gastrointestinal tract and infections with antibiotic-resistant bacterial pathogens, and to the research and search for new agents.

Tübingen is the coordinating body within DZIF for the focal topics of malaria and infections with antibiotic-resistant bacterial pathogens. Malaria research is currently focussing on the translational aspects, in particular drug and vaccine development, new infection models and epidemiology. Research into infections caused by antibiotic-resistant bacterial pathogens is focussed on improving the diagnosis and therapy of multiresistant pathogens such as methicillin-resistant Staphylococci (MRSA) and gram-negative pathogens (e.g. ESBL).

Other topics of importance to the Tübingen researchers are the search for new biomarkers for GI tract infections and agents against the responsible pathogens, and the search for and research into new anti-infective agents using novel methods and techniques, e.g. genome-mining and combinatorial biosynthesis. Alongside its involvement in other research, such as infections in immunocompromised patients and tuberculosis, Tübingen also supports the infrastructural areas throughout DZIF including, for instance, the DZIF Academy, with measures to improve the training of junior researchers on infection research, and the areas of clinical studies, bioinformatics and biobanking.

Partner site speaker
Ingo Autenrieth (Eberhard Karls Universität Tübingen)

Deputy partner site speaker
Peter Kremsner (Eberhard Karls Universität Tübingen)

Partner site manager   
Dirk Kraus (Eberhard Karls Universität Tübingen)  

Research institutions involved

Eberhard Karls Universität Tübingen
University Hospital Tübingen
Max Planck Institute for Developmental Biology